Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 8, 2022
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational StudyBenedetta Maria Bonora, Roberta Cappellari, Marco Grasso, et al.
Cardiovascular Diabetology|January 19, 2018
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complicationsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Atherosclerosis|October 11, 2017
Shift of monocyte subsets along their continuum predicts cardiovascular outcomesRoberta Cappellari, Marianna D'Anna, Benedetta Maria Bonora, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 24, 2007
New MultiPEG-conjugated theophylline derivatives: synthesis and pharmacological evaluationsMarina Zacchigna, Gabriella Di Luca, Francesca Cateni, et al.
Diabetologia|April 20, 2020
Diabetes mellitus impairs circulating proangiogenic granulocytesRoberta Cappellari, Marianna D'Anna, Lisa Menegazzo, et al.
Diabetes, Obesity & Metabolism|December 23, 2018
Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studiesGian Paolo Fadini, Bendetta Maria Bonora, Annunziata Lapolla, et al.
Diabetes Research and Clinical Practice|August 28, 2021
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studiesEnrico Longato, Benedetta Maria Bonora, Barbara Di Camillo, et al.
European Heart Journal|January 1, 2020
Circulating stem cells and cardiovascular outcomes: from basic science to the clinicGian Paolo Fadini, Anurag Mehta, Devinder Singh Dhindsa, et al.
Cancers|June 19, 2024
Current Status and Future Directions of Proton Therapy for Head and Neck CarcinomaSara Lillo, Alfredo Mirandola, Alessandro Vai, et al.
Cardiovascular Diabetology|April 6, 2017
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialGian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, et al.
Pageof 10